These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


342 related items for PubMed ID: 19164294

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Alteration of chondroitin sulfate composition on proteoglycan produced by knock-in mouse embryonic fibroblasts whose versican lacks the A subdomain.
    Suwan K, Hatano S, Kongtawelert P, Pothacharoen P, Watanabe H.
    Ups J Med Sci; 2009; 114(2):73-81. PubMed ID: 19396693
    [Abstract] [Full Text] [Related]

  • 3. Versican A-subdomain is required for its adequate function in dermal development.
    Hatano S, Nagai N, Sugiura N, Tsuchimoto J, Isogai Z, Kimata K, Ota A, Karnan S, Hosokawa Y, Watanabe H.
    Connect Tissue Res; 2018 Mar; 59(2):178-190. PubMed ID: 28488903
    [Abstract] [Full Text] [Related]

  • 4. Versican/PG-M is essential for ventricular septal formation subsequent to cardiac atrioventricular cushion development.
    Hatano S, Kimata K, Hiraiwa N, Kusakabe M, Isogai Z, Adachi E, Shinomura T, Watanabe H.
    Glycobiology; 2012 Sep; 22(9):1268-77. PubMed ID: 22692047
    [Abstract] [Full Text] [Related]

  • 5. V3 versican isoform alters the behavior of human melanoma cells by interfering with CD44/ErbB-dependent signaling.
    Hernández D, Miquel-Serra L, Docampo MJ, Marco-Ramell A, Cabrera J, Fabra A, Bassols A.
    J Biol Chem; 2011 Jan 14; 286(2):1475-85. PubMed ID: 21078678
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hyaluronan and versican in the control of human T-lymphocyte adhesion and migration.
    Evanko SP, Potter-Perigo S, Bollyky PL, Nepom GT, Wight TN.
    Matrix Biol; 2012 Mar 14; 31(2):90-100. PubMed ID: 22155153
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The versican-hyaluronan complex provides an essential extracellular matrix niche for Flk1+ hematoendothelial progenitors.
    Nandadasa S, O'Donnell A, Murao A, Yamaguchi Y, Midura RJ, Olson L, Apte SS.
    Matrix Biol; 2021 Mar 14; 97():40-57. PubMed ID: 33454424
    [Abstract] [Full Text] [Related]

  • 14. Rhamm-/- fibroblasts are defective in CD44-mediated ERK1,2 motogenic signaling, leading to defective skin wound repair.
    Tolg C, Hamilton SR, Nakrieko KA, Kooshesh F, Walton P, McCarthy JB, Bissell MJ, Turley EA.
    J Cell Biol; 2006 Dec 18; 175(6):1017-28. PubMed ID: 17158951
    [Abstract] [Full Text] [Related]

  • 15. Altered expression of versican and hyaluronan in melanocytic tumors of dogs.
    Docampo MJ, Rabanal RM, Miquel-Serra L, Hernández D, Domenzain C, Bassols A.
    Am J Vet Res; 2007 Dec 18; 68(12):1376-85. PubMed ID: 18052744
    [Abstract] [Full Text] [Related]

  • 16. Isolation and Purification of Versican and Analysis of Versican Proteolysis.
    Foulcer SJ, Day AJ, Apte SS.
    Methods Mol Biol; 2022 Dec 18; 2303():559-578. PubMed ID: 34626407
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hyaluronan fragments/CD44 mediate oxidative stress-induced MUC5B up-regulation in airway epithelium.
    Casalino-Matsuda SM, Monzon ME, Day AJ, Forteza RM.
    Am J Respir Cell Mol Biol; 2009 Mar 18; 40(3):277-85. PubMed ID: 18757307
    [Abstract] [Full Text] [Related]

  • 19. Hyaluronan, CD44 and versican in epidermal keratinocyte tumours.
    Karvinen S, Kosma VM, Tammi MI, Tammi R.
    Br J Dermatol; 2003 Jan 18; 148(1):86-94. PubMed ID: 12534600
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.